- Home
- ATRA vs XTNT Comparison
ATRA vs XTNT Comparison
Compare ATRA & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- XTNT
- Stock Information
- Founded
- ATRA 2012
- XTNT N/A
- Country
- ATRA United States
- XTNT United States
- Employees
- ATRA N/A
- XTNT N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATRA Health Care
- XTNT Health Care
- Exchange
- ATRA Nasdaq
- XTNT Nasdaq
- Market Cap
- ATRA 65.1M
- XTNT 55.6M
- IPO Year
- ATRA 2014
- XTNT N/A
- Fundamental
- Price
- ATRA $11.40
- XTNT $0.38
- Analyst Decision
- ATRA Buy
- XTNT Strong Buy
- Analyst Count
- ATRA 6
- XTNT 1
- Target Price
- ATRA $26.50
- XTNT $3.00
- AVG Volume (30 Days)
- ATRA 77.5K
- XTNT 224.7K
- Earning Date
- ATRA 11-12-2024
- XTNT 11-12-2024
- Dividend Yield
- ATRA N/A
- XTNT N/A
- EPS Growth
- ATRA N/A
- XTNT N/A
- EPS
- ATRA N/A
- XTNT N/A
- Revenue
- ATRA $100,439,000.00
- XTNT $113,862,000.00
- Revenue This Year
- ATRA $1,346.63
- XTNT $31.82
- Revenue Next Year
- ATRA N/A
- XTNT $13.64
- P/E Ratio
- ATRA N/A
- XTNT N/A
- Revenue Growth
- ATRA 2111.34
- XTNT 45.11
- 52 Week Low
- ATRA $6.50
- XTNT $0.33
- 52 Week High
- ATRA $39.50
- XTNT $1.31
- Technical
- Relative Strength Index (RSI)
- ATRA 51.71
- XTNT 35.87
- Support Level
- ATRA $9.13
- XTNT $0.35
- Resistance Level
- ATRA $13.64
- XTNT $0.39
- Average True Range (ATR)
- ATRA 0.96
- XTNT 0.02
- MACD
- ATRA -0.27
- XTNT 0.00
- Stochastic Oscillator
- ATRA 50.33
- XTNT 56.22
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.